Emily Truong

1.0k total citations
15 papers, 382 citations indexed

About

Emily Truong is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Emily Truong has authored 15 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Hepatology and 4 papers in Surgery. Recurrent topics in Emily Truong's work include Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Emily Truong is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Liver Disease and Transplantation (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Emily Truong collaborates with scholars based in United States, United Kingdom and Singapore. Emily Truong's co-authors include Mazen Noureddin, Naim Alkhouri, Ju Dong Yang, Nabil Noureddin, Stephen A. Harrison, Tsuyoshi Todo, Maha Guindi, Jeffrey Gornbein, Rola Saouaf and Christie Y. Jeon and has published in prestigious journals such as Hepatology, Journal of Hepatology and Clinical Gastroenterology and Hepatology.

In The Last Decade

Emily Truong

15 papers receiving 375 citations

Peers

Countries citing papers authored by Emily Truong

Since Specialization

Citations

This map shows the geographic impact of Emily Truong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Truong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Truong more than expected).

Fields of papers citing papers by Emily Truong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Truong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Truong. The network helps show where Emily Truong may publish in the future.

Co-authorship network of co-authors of Emily Truong

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Truong. A scholar is included among the top collaborators of Emily Truong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Truong. Emily Truong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Multiparametric magnetic resonance imaging may improve detection of patients with at-risk MASH: Real world experience in hepatology clinics 2025 ·Digestive and Liver Disease ·Meaghan Phipps, (unknown), Emily Truong, Soo Young Hwang, (unknown), Andrea Dennis, Elizabeth Shumbayawonda, Prashant Pandya, Julia Wattacheril	2
2	Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLD 2025 ·Digestive Diseases and Sciences ·Emily Truong, (unknown), Jeffrey Gornbein, Ju Dong Yang, Naim Alkhouri, Stephen A. Harrison, Mazen Noureddin	2
3	Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores 2023 ·Hepatology Communications ·Mazen Noureddin, Edward Mena, Raj Vuppalanchi, Niharika Samala, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Nabil Noureddin, Anita Kohli, Stephen Harrison, Samer Gawrieh, Naim Alkhouri, Emily Truong	24
4	Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study 2023 ·Hepatology ·Beom Kyung Kim, Jaclyn Bergstrom, (unknown), Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idılman, Mesut Gümüşsoy, Diğdem Kuru Öz, Ayşe Erden, Emily Truong, Ju Dong Yang, Mazen Noureddin, Alina M. Allen, Rohit Loomba, Veeral Ajmera	14
5	Risk Stratification for Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver Disease 2023 ·Current Hepatology Reports ·Emily Truong, Cheng Han, Mark Muthiah, Mazen Noureddin	3
6	MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Death 2023 ·Clinical Gastroenterology and Hepatology ·Emily Truong, Jeffrey Gornbein, Ju Dong Yang, Nabil Noureddin, Stephen A. Harrison, Naim Alkhouri, Mazen Noureddin	21
7	The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease 2022 ·Clinics in Liver Disease ·Emily Truong, Mazen Noureddin	11
8	Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer 2022 ·EBioMedicine ·Emily Truong, Stephen J. Pandol, Christie Y. Jeon	26
9	Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017–2018 2022 ·Hepatology Communications ·Emily Truong, Yee Hui Yeo, Galen Cook‐Wiens, Mark Muthiah, Ju Dong Yang, Vinay Sundaram, (unknown), Tsuyoshi Todo, Irene Kim, Shelly C. Lu, Veronica Wendy Setiawan, Vincent Wai‐Sun Wong, Stephen A. Harrison, Naim Alkhouri, Mazen Noureddin	24
10	Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update 2022 ·Seminars in Liver Disease ·Nicholas Chew, Cheng Han Ng, Emily Truong, Mazen Noureddin, Kris V. Kowdley	21
11	Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD‐related cirrhosis 2022 ·Hepatology ·(unknown), Emily Truong, Edward Mena, (unknown), (unknown), Maha Guindi, Tsuyoshi Todo, Nabil Noureddin, Walid S. Ayoub, Ju Dong Yang, Irene Kim, Anita Kohli, Naim Alkhouri, Stephen A. Harrison, Mazen Noureddin	43
12	Improvement in nonalcoholic fatty liver disease through bariatric surgery 2022 ·Clinical Liver Disease ·Emily Truong, Mazen Noureddin	8
13	MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis 2021 ·Journal of Hepatology ·Mazen Noureddin, Emily Truong, Jeffrey Gornbein, Rola Saouaf, Maha Guindi, Tsuyoshi Todo, Nabil Noureddin, Ju Dong Yang, Stephen A. Harrison, Naim Alkhouri	117
14	Avoidant Restrictive Food Intake Disorder Prevalent Among Patients With Inflammatory Bowel Disease 2021 ·Clinical Gastroenterology and Hepatology ·(unknown), Emily Truong, (unknown), Giselle Pignotti, Liu Yang, (unknown), (unknown), (unknown), (unknown), Jenny Sauk, Berkeley N. Limketkai	50
15	Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis 2018 ·Journal of Clinical Gastroenterology ·Elizabeth S. Aby, Jennifer Phan, Emily Truong, Jonathan Grotts, Sammy Saab	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact